S&P Futures
4,309.75 +2.00 (+0.05%) Dow Futures
34,143.00 +25.00 (+0.07%) Nasdaq Futures
13,653.50 -4.75 (-0.03%) Russell 2000 Futures
2,025.80 +2.50 (+0.12%) Crude Oil
87.17 +0.64 (+0.74%) Gold
1,792.60 +2.90 (+0.16%)
uniQure N.V. (QURE)
After hours:
- Simply Wall St.
These Analysts Just Made A Neat Downgrade To Their uniQure N.V. (NASDAQ:QURE) EPS Forecasts
The latest analyst coverage could presage a bad day for uniQure N.V. ( NASDAQ:QURE ), with the analysts making...
- Motley Fool
Why uniQure Stock Is Crashing Today
Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.
- Benzinga
Why UniQure Shares Are Plummeting Today?
Tucked in its Q2 earnings release, UniQure N.V. (NASDAQ: QURE) said that in July, it had observed suspected, unexpected severe adverse reactions (SUSARs) in two patients after they were treated with the "higher dose" of AMT-130 in a European Phase 1b/2 trial. AMT-130 is a gene therapy candidate for Huntington's disease. A third patient treated back in March in the U.S., had their side effect deemed unrelated to the candidate, but it was then reclassified as a severe adverse reaction after review
